These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 7976403)
1. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed. Ralevic V; Edvinsson L; Burnstock G Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403 [TBL] [Abstract][Full Text] [Related]
2. D-myo-inositol 1,2,6-trisphosphate blocks neuropeptide Y-induced facilitation of noradrenaline-evoked vasoconstriction of the mesenteric bed. Donoso MV; Boric M; Prado M; Fournier A; St Pierre S; Edvinsson L; Huidobro-Toro JP Eur J Pharmacol; 1993 Aug; 240(1):93-7. PubMed ID: 8405129 [TBL] [Abstract][Full Text] [Related]
3. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature. Sun X; You J; Hedner T; Erlinge D; Fellström B; Yoo H; Wahlestedt C; Edvinsson L J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501 [TBL] [Abstract][Full Text] [Related]
4. Augmented sensory-motor vasodilatation of the rat mesenteric arterial bed after chronic infusion of the P1-purinoceptor antagonist, DPSPX. Relevic V; Rubino A; Burnstock G Br J Pharmacol; 1996 Aug; 118(7):1675-80. PubMed ID: 8842431 [TBL] [Abstract][Full Text] [Related]
5. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed. Donoso MV; Steiner M; Huidobro-Toro JP J Pharmacol Exp Ther; 1997 Aug; 282(2):691-8. PubMed ID: 9262332 [TBL] [Abstract][Full Text] [Related]
6. Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins. Ralevic V; Burnstock G Br J Pharmacol; 1996 Apr; 117(7):1463-70. PubMed ID: 8730740 [TBL] [Abstract][Full Text] [Related]
7. Prejunctional modulation of sensory-motor nerve-mediated vasodilatation of the rat mesenteric arterial bed by opioid peptides. Ralevic V; Rubino A; Burnstock G J Pharmacol Exp Ther; 1994 Feb; 268(2):772-8. PubMed ID: 8113989 [TBL] [Abstract][Full Text] [Related]
8. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226. Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522 [TBL] [Abstract][Full Text] [Related]
9. Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats. Ralevic V; Belai A; Burnstock G Br J Pharmacol; 1993 Nov; 110(3):1105-11. PubMed ID: 8298799 [TBL] [Abstract][Full Text] [Related]
10. Modulation by nicotinamide adenine dinucleotide of sympathetic and sensory-motor neurotransmission via P1-purinoceptors in the rat mesenteric arterial bed. Ralevic V Br J Pharmacol; 1995 Apr; 114(8):1541-8. PubMed ID: 7599921 [TBL] [Abstract][Full Text] [Related]
11. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C. Bell D; Millar BC; McDermott BJ Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. Pernow J; Saria A; Lundberg JM Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640 [TBL] [Abstract][Full Text] [Related]
13. Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y. Chen H; Bischoff A; Schäfers RF; Wambach G; Philipp T; Michel MC J Auton Pharmacol; 1997 Jun; 17(3):137-46. PubMed ID: 9278773 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate). Adamsson M; Fallgren B; Edvinsson L Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693 [TBL] [Abstract][Full Text] [Related]
15. Autoradiographic localization and characterization of [3H]alpha-trinositol (1D-myo-inositol 1,2,6-trisphosphate) binding sites in human and mammalian tissues. Walsh DA; Mapp PI; Polak JM; Blake DR J Pharmacol Exp Ther; 1995 Apr; 273(1):461-9. PubMed ID: 7714802 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Sun X; Edvinsson L; Hedner T J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175 [TBL] [Abstract][Full Text] [Related]
17. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery. Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498 [TBL] [Abstract][Full Text] [Related]
18. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y. Schwieler JH; Hjemdahl P J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493 [TBL] [Abstract][Full Text] [Related]
19. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat. Sun XY; Edvinsson L; Hedner T J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors. Donoso MV; Brown N; Carrasco C; Cortes V; Fournier A; Huidobro-Toro JP J Neurochem; 1997 Sep; 69(3):1048-59. PubMed ID: 9282927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]